Trial Information

A Prospective Study About Complications of Totally Implantable Central Venous Access Ports in People With CF

To be included in the study, subjects need to fulfil the following requirements:

- Diagnosis of CF, made accordingly to the CF Foundation Guideline;

- Ability to consciously express owns informed consent, if aged 18 or more. If minor,
presence of at least one legally authorised parent able to consciously express informed
consent;

- Have a TIVAD implanted;

- Have no current complications in the TIVAD (infection, thromboembolic complications or
occlusion) Outcome Measures

Measured outcomes will be:

1. Incidence of TIVAD infections (Port pocket infection, Cutaneous site
infection,Catheter-related infection;

2. Incidence of TIVAD thrombosis;

3. Incidence of TIVAD occlusion.

The observational phase will last 12 months for each subject involved